Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Discover how U.S. trade tariffs and proposed Medicaid cuts could reshape workers’ comp costs and care access. Dave Torrence outlines key risks and strategies in WorkCompWire’s "Leaders Speak" article.
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
Discover how vocational case management can reduce claim costs and improve return-to-work outcomes. Essential guide for claims professionals seeking efficient claim resolution.
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp. Discover what this breakthrough could mean for pain management and claims strategies.
The Implications of Trump's Health Care Executive Order for Workers' Compensation and Auto Insurers
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.